ClinVar Miner

Submissions for variant NM_000271.5(NPC1):c.1947+5G>C

gnomAD frequency: 0.00001  dbSNP: rs770321568
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000357223 SCV000333007 likely pathogenic not provided 2018-02-20 criteria provided, single submitter clinical testing
Counsyl RCV000670237 SCV000795068 uncertain significance Niemann-Pick disease, type C1 2017-10-31 criteria provided, single submitter clinical testing
Invitae RCV000670237 SCV002285585 pathogenic Niemann-Pick disease, type C1 2023-06-04 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the NPC1 protein in which other variant(s) (p.Gly640Arg) have been determined to be pathogenic (PMID: 12955717, 27581084). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in the activation of a cryptic splice site in exon 12 (PMID: 28328115). Studies have shown that this variant alters NPC1 gene expression (PMID: 30202070). ClinVar contains an entry for this variant (Variation ID: 281945). This variant has been observed in individual(s) with Niemann-Pick Type C (PMID: 28328115). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change falls in intron 12 of the NPC1 gene. It does not directly change the encoded amino acid sequence of the NPC1 protein. RNA analysis indicates that this variant induces altered splicing and likely results in the loss of 25 amino acid residue(s), but is expected to preserve the integrity of the reading-frame.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002222467 SCV002500776 likely pathogenic Niemann-Pick disease, type C 2022-03-30 criteria provided, single submitter clinical testing Variant summary: NPC1 c.1947+5G>C alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: One predicts the variant abolishes a 5' splicing donor site and three predict the variant weakens a 5' donor site. Experimental evidence supports these predictions indicating the variant affects mRNA splicing (Salman_2017). The variant allele was found at a frequency of 8e-06 in 249836 control chromosomes (gnomAD). c.1947+5G>C has been reported in the literature in individuals affected with Niemann-Pick Disease (e.g. Mazzacuva_2016, Salman_2017, Schultz_2018). These data indicate that the variant may be associated with disease. Three ClinVar submitters have assessed the variant since 2014: one classified the variant as of uncertain significance, and two as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
PreventionGenetics, part of Exact Sciences RCV003391029 SCV004119928 pathogenic NPC1-related disorder 2023-08-25 criteria provided, single submitter clinical testing The NPC1 c.1947+5G>C variant is predicted to interfere with splicing. This variant has been reported in individuals with Niemann-Pick disease, type C (Salman et al. 2017. PubMed ID: 28328115; Table S1, Mazzacuva et al. 2016. PubMed ID: 27139891). In vitro functional studies demonstrate this variant affects splicing as well as has an effect on NPC1 function (Figure 1C and D, Salman et al 2017. PubMed ID: 28328115; Figure 1D, Schultz et al. 2018. PubMed ID: 30202070 ). This variant is reported in 0.0018% of alleles in individuals of European (non-Finnish) descent in gnomAD ( This variant is interpreted as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.